LifeBee, a ProductLife Group (PLG) company, has been recognized by EcoVadis for its sustainability performance, marking an important step in the organization’s ongoing commitment to responsible business practices.
EcoVadis is one of the most widely used global platforms for assessing corporate sustainability, evaluating companies across four key dimensions: environment, labour and human rights, ethics, and sustainable procurement. The assessment provides an independent benchmark that allows organizations to measure their environmental, social, and governance (ESG) performance and identify opportunities for continuous improvement.
For LifeBee, this recognition reflects a structured approach to sustainability that combines ethical governance, operational responsibility, and long-term value creation within the Life Sciences ecosystem.
LifeBee’s recognition is part of a broader sustainability journey within ProductLife Group. Across the Group, ESG principles are increasingly embedded in governance, operational processes, and service delivery.
ProductLife Group has strengthened its sustainability framework through initiatives such as enhanced governance policies, responsible procurement practices, improved carbon accounting, and reinforced ethics and compliance programs.
More broadly, the Group continues to align its sustainability strategy with internationally recognized frameworks and global ESG priorities, ensuring that sustainability becomes an integral part of how the organization operates and supports the Life Sciences industry.
Within this context, LifeBee contributes through its expertise in digital consulting, IT validation, and regulatory compliance, supporting organizations in highly regulated environments.
The Life Sciences sector operates in a complex regulatory landscape where quality, compliance, and data integrity are essential. At the same time, companies are increasingly expected to integrate sustainability considerations into their operations and decision-making processes.
Digital transformation initiatives—such as the implementation of validated digital systems, improved data governance, and efficient quality management frameworks—can play a key role in enabling both compliance and operational sustainability.
Through its consulting services in digital quality, IT validation, and GxP-regulated environments, LifeBee helps Life Sciences organizations strengthen their operational foundations while supporting more efficient and responsible processes across the product lifecycle.
Sustainability is not a single milestone but an ongoing journey of improvement, transparency, and collaboration. Across ProductLife Group and its affiliates, shared learning and coordinated initiatives contribute to strengthening sustainability practices across the entire organization.
This collective approach helps ensure that ESG principles are embedded not only in governance structures but also in everyday activities, from internal operations to client engagements.
For LifeBee, the EcoVadis recognition represents both an achievement and an opportunity to continue advancing responsible practices while supporting innovation in the Life Sciences sector.
As sustainability expectations continue to evolve across the healthcare and Life Sciences industries, organizations must balance innovation with responsibility, transparency, and regulatory compliance.
By combining digital expertise, regulatory knowledge, and quality-driven consulting, LifeBee remains committed to supporting Life Sciences companies in navigating complex regulatory environments while contributing to more sustainable and resilient operations.
The EcoVadis recognition highlights the importance of this ongoing commitment and reinforces the role of responsible consulting in shaping the future of the Life Sciences ecosystem.
LifeBee welcomes everyone at booth #304 to participate in the 2024 ISPE Europe Annual Conference in Lisbon to learn and share progress, success stories, best practices, and lessons learned. Discover how we support Life Sciences companies to digitalize their business.
This ISPE European Annual Conference brings together professionals from the pharmaceutical and biopharmaceutical industries. The event is designed for individuals at all levels of the industry, including students, emerging leaders, and senior executives in drug manufacturing, supply chain, devices, equipment and services, and global regulatory agencies.
Our team will be there to discuss 5 key topics:
Digital Transformation: Use Cases, Key Benefits, and Lessons Learned
Explore the potential of Digital Transformation and Pharma 4.0™ projects within the Life Science Industry.
Meet our Teresa Minero event co-chair and speaker with the speech: “Charting Pharma’s Digital Journey: Insight from the Pharma 4.0™ 7th Edition Study: Deep Dive Latest Correlation and Trends” with Laura Kuger from Karlsruhe Institute of Technology (KIT). They will share an update on maturity, adoption of enabling technologies, benefits, challenges, and industry sentiment around 4.0 from Life Sciences companies.
Don’t miss this speech on April 17th at 13:45 (CET) Track 1 “Digital Transformation”.
Learnings from GXP Inspections to Prepare for the Future
Inspections and compliance assessment remain a core aspect of pharmaceutical regulation.
Regulatory Restrictions and Drug Availability
Improving the availability of authorized medicines is a key priority for the medicines regulatory network.
GAMP® 5, FDA CSA, cloud computing SAAS, eBatch records with Pharma 4.0
Discover how GAMP 5 Second Edition has had an impact on the pharmaceutical industry.
Meet ours Raffaella Vaiani and Marco Torciani.
Good Engineering Practice and Efficient Investment Management
Attendees will learn the ins and outs of the European projects that were recognized with the ISEP Facility of the Year award (FOYA) in 2023.
Our team is excited to share insights and explore new opportunities in the pharmaceutical industry. make an appointment by writing to info@lifebee.it you can book your appointment with:
- Teresa Minero
- Raffaella Vaiani
- Marco Torciani
- Almudena Del Castillo Saiz
- Wendy Morales Oviedo
LifeBee, A ProductLifeGroup Company, is always at the forefront of digital transformation and innovation in Life Sciences.
By attending this conference, you'll have the chance to expand your knowledge and network with like-minded professionals. Don't miss out on this valuable experience; register NOW to secure your spot at the conference.
Our Founder & CEO Teresa Minero had the privilege to hold the introductory speech for the "2nd EMA QIG's Listen & Learn Focus Group meeting".
It has been a two-days of hybrid meeting organized by EMA Quality Innovation Group: many stakeholders by European Medicines Agency, EU Agencies, FDA and PMDA - Japan Pharmaceuticals and Medical Device Agency, Academy, Industry, Association and relevant providers of pharma applications based on novel digital technologies were present.
Title of the speech of Teresa "Innovative Technologies in regulated Pharma: a high level summary from ISPE Pharma 4.0tm Surveys plus 35 selected and structured Case Studies with an analysis of: triggers, solutions, innovative tech, involved departments, benefits, challenges and lessons learned".
Teresa Minero and Raffaella Vaiani will be among the speakers of the 10th edition of Pharmaconex - Africa’s and Middle East’s pharmaceutical manufacturing hub, gathering over 6.000 industry professionals in Cairo, from 3th to 5th of September.
They will participate as speakers during the Technical Conference - supported by ISPE and sponsored by AGON -, to share their expertise on digital transformation in pharma.
Teresa Minero will be holding one of the opening speech of the first day of technical conference, delving into the ISPE Pharma 4.0 Survey, unveiling strategies to enhance digital maturity.
Following, Raffaella Vaiani will discuss digital transformation roadmaps to achieve compliance to regulations, deepening with use case on Annex1 and quality metrics.
We are honored to join this prominent appointment for the pharma industry in MENA region, and to share our knowledge and insight on the latest innovations and challenges facing the pharmaceutical industry.
Our Teresa Minero at the 2023 ISPE Facilities of the Future Conference (Bethesda, Washington), presenting the "Latest Results and Trends in Pharma 4.0™” from the 6th edition of the ISPE survey.
This edition focus was on the state of adoption of the various enabling technologies and benefits, particularly in the Quality & Compliance area.
Did you miss the speech?
Contact us to get updated: info@lifebee.it
Our Founder & CEO Teresa Minero will lead the first session presenting the results of the 5th ISPE Pharma 4.0™ Survey, outlining the updates regarding maturity levels, adopted technologies, benefits and challenges.
Relevant subject matter experts will then discuss practical solutions and challenges from technical, managerial and regulatory perspectives. Participants will also have the opportunity to engage with industry leaders and peers in a 30’ virtual networking event.
LifeBee is always active in the Pharma 4.0™ debate and we are present also as a Sponsor.
Connect at 15:00 CET, complimentary registration here
Don’t miss it!
Teresa Minero opening the Panel Session on "Digitalisation of Pharmaceutical Industry" at the Eurasian ISPE Annual Conference with a speech "Where are we on Pharma 4.0™?"
Teresa: "It was an honour and a pleasure to be part today to the ISPE Eurasian conference in Moscow, even if virtually. Great opportunity to share the latest regulatory trends and how 4.0 in Pharma is playng a key role to be compliant".
Today Teresa Minero took part as Speaker, at the second Regional Conference on Industrial Development, under the theme “Acceleration of Industry 4.0 for inclusive and sustainable industralization”, organized by the Government of Indonesia in partnership with United Nations Industrial Development Organization - UNIDO.
It was a pleasure and an honor for LifeBee to attend this session and to share knowledge on Pharma 4.0 Industry!
Our CEO Teresa Minero is among the speakers of the "2nd Pharma 4.0 Smart Manufacturing Summit", dedicated to exploring how Industry 4.0 changes pharmaceutical manufacturing and how the transition to Pharma 4.0 offers new opportunities and challenges at the same time.
Join the event for her speech “4.0 in Pharma: compliance to regulations and business benefits” today at 15:50
Organised by Vonlanthen Group more infos here
We are proud to announce that our lead Teresa Minero has been awarded among the Top 25 CEO of Europe for 2021 by The Healthcare Technology Report
"The Healthcare Technology Report is pleased to announce The Top 25 Healthcare Technology CEOs of Europe for 2021. As the coronavirus continues to impact populations in various parts of the world, a brighter light has shone on the critical importance of healthcare innovation across biotechnology, medical devices, software, and consumer products, among other areas. European healthcare technology CEOs have demonstrated impressive leadership over the past year while adapting to increased demand as well as shifting priorities in the market. Despite the myriad of challenges presented in the current environment, this year’s awardees have led their organizations ably (...)"
Read the full article here
In association with
In support of:
USEFUL LINK
Codice Etico
CSR
Associazioni
Privacy policy
Cookies
Whistleblowing
Organogram
Intranet
NEWSLETTER
P.IVA
IT04374150961
(other infos)
Stay connected!
